Statistics

Total Visits

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study40

Select a period of time:

Number of views in the range

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study25

Views

Views
January 20251
February 20252
March 202514
April 20252
May 20253
June 20253
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore19
United States5
Spain1
 

Top cities views

Views
Council Bluffs1
Dallas1
Huntington Beach1
Metter1
Pasadena1